1 Fibroblast Growth Factor 2 Market Overview 1.1 Product Overview and Scope of Fibroblast Growth Factor 2 1.2 Fibroblast Growth Factor 2 Segment by Type 1.2.1 Global Fibroblast Growth Factor 2 Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 CT-400P 1.2.3 DVC-10101 1.2.4 NK-4 1.2.5 RBM-007 1.2.6 Others 1.3 Fibroblast Growth Factor 2 Segment by Application 1.3.1 Fibroblast Growth Factor 2 Sales Comparison by Application: (2021-2027) 1.3.2 Achondroplasia 1.3.3 Bone Diorders 1.3.4 Cancer Pain 1.3.5 Pancreatic Cancer 1.3.6 Others 1.4 Global Fibroblast Growth Factor 2 Market Size Estimates and Forecasts 1.4.1 Global Fibroblast Growth Factor 2 Revenue 2016-2027 1.4.2 Global Fibroblast Growth Factor 2 Sales 2016-2027 1.4.3 Fibroblast Growth Factor 2 Market Size by Region: 2016 Versus 2021 Versus 2027 2 Fibroblast Growth Factor 2 Market Competition by Manufacturers 2.1 Global Fibroblast Growth Factor 2 Sales Market Share by Manufacturers (2016-2021) 2.2 Global Fibroblast Growth Factor 2 Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Fibroblast Growth Factor 2 Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Fibroblast Growth Factor 2 Manufacturing Sites, Area Served, Product Type 2.5 Fibroblast Growth Factor 2 Market Competitive Situation and Trends 2.5.1 Fibroblast Growth Factor 2 Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Fibroblast Growth Factor 2 Players Market Share by Revenue 2.5.3 Global Fibroblast Growth Factor 2 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Fibroblast Growth Factor 2 Retrospective Market Scenario by Region 3.1 Global Fibroblast Growth Factor 2 Retrospective Market Scenario in Revenue by Region: 2016-2021 3.2 Global Fibroblast Growth Factor 2 Retrospective Market Scenario in Sales by Region: 2016-2021 3.3 North America Fibroblast Growth Factor 2 Market Facts & Figures by Country 3.3.1 North America Fibroblast Growth Factor 2 Sales by Country 3.3.2 North America Fibroblast Growth Factor 2 Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Fibroblast Growth Factor 2 Market Facts & Figures by Country 3.4.1 Europe Fibroblast Growth Factor 2 Sales by Country 3.4.2 Europe Fibroblast Growth Factor 2 Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Fibroblast Growth Factor 2 Market Facts & Figures by Region 3.5.1 Asia Pacific Fibroblast Growth Factor 2 Sales by Region 3.5.2 Asia Pacific Fibroblast Growth Factor 2 Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Fibroblast Growth Factor 2 Market Facts & Figures by Country 3.6.1 Latin America Fibroblast Growth Factor 2 Sales by Country 3.6.2 Latin America Fibroblast Growth Factor 2 Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Fibroblast Growth Factor 2 Market Facts & Figures by Country 3.7.1 Middle East and Africa Fibroblast Growth Factor 2 Sales by Country 3.7.2 Middle East and Africa Fibroblast Growth Factor 2 Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Fibroblast Growth Factor 2 Historic Market Analysis by Type 4.1 Global Fibroblast Growth Factor 2 Sales Market Share by Type (2016-2021) 4.2 Global Fibroblast Growth Factor 2 Revenue Market Share by Type (2016-2021) 4.3 Global Fibroblast Growth Factor 2 Price by Type (2016-2021) 5 Global Fibroblast Growth Factor 2 Historic Market Analysis by Application 5.1 Global Fibroblast Growth Factor 2 Sales Market Share by Application (2016-2021) 5.2 Global Fibroblast Growth Factor 2 Revenue Market Share by Application (2016-2021) 5.3 Global Fibroblast Growth Factor 2 Price by Application (2016-2021) 6 Key Companies Profiled 6.1 ID Pharma Co Ltd 6.1.1 ID Pharma Co Ltd Corporation Information 6.1.2 ID Pharma Co Ltd Description and Business Overview 6.1.3 ID Pharma Co Ltd Fibroblast Growth Factor 2 Sales, Revenue and Gross Margin (2016-2021) 6.1.4 ID Pharma Co Ltd Product Portfolio 6.1.5 ID Pharma Co Ltd Recent Developments/Updates 6.2 Kringle Pharma Inc 6.2.1 Kringle Pharma Inc Corporation Information 6.2.2 Kringle Pharma Inc Description and Business Overview 6.2.3 Kringle Pharma Inc Fibroblast Growth Factor 2 Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Kringle Pharma Inc Product Portfolio 6.2.5 Kringle Pharma Inc Recent Developments/Updates 6.3 Ohr Pharmaceutical Inc 6.3.1 Ohr Pharmaceutical Inc Corporation Information 6.3.2 Ohr Pharmaceutical Inc Description and Business Overview 6.3.3 Ohr Pharmaceutical Inc Fibroblast Growth Factor 2 Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Ohr Pharmaceutical Inc Product Portfolio 6.3.5 Ohr Pharmaceutical Inc Recent Developments/Updates 6.4 Ribomic Inc 6.4.1 Ribomic Inc Corporation Information 6.4.2 Ribomic Inc Description and Business Overview 6.4.3 Ribomic Inc Fibroblast Growth Factor 2 Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Ribomic Inc Product Portfolio 6.4.5 Ribomic Inc Recent Developments/Updates 7 Fibroblast Growth Factor 2 Manufacturing Cost Analysis 7.1 Fibroblast Growth Factor 2 Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Fibroblast Growth Factor 2 7.4 Fibroblast Growth Factor 2 Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Fibroblast Growth Factor 2 Distributors List 8.3 Fibroblast Growth Factor 2 Customers 9 Fibroblast Growth Factor 2 Market Dynamics 9.1 Fibroblast Growth Factor 2 Industry Trends 9.2 Fibroblast Growth Factor 2 Growth Drivers 9.3 Fibroblast Growth Factor 2 Market Challenges 9.4 Fibroblast Growth Factor 2 Market Restraints 10 Global Market Forecast 10.1 Fibroblast Growth Factor 2 Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Fibroblast Growth Factor 2 by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Fibroblast Growth Factor 2 by Type (2022-2027) 10.2 Fibroblast Growth Factor 2 Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Fibroblast Growth Factor 2 by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Fibroblast Growth Factor 2 by Application (2022-2027) 10.3 Fibroblast Growth Factor 2 Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Fibroblast Growth Factor 2 by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Fibroblast Growth Factor 2 by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Fibroblast Growth Factor 2 Sales (K Pcs) Growth Rate Comparison by Type (2021-2027) Table 2. Global Fibroblast Growth Factor 2 Sales (K Pcs) Comparison by Application (2021-2027) Table 3. Global Fibroblast Growth Factor 2 Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Fibroblast Growth Factor 2 Covered in This Study Table 5. Global Fibroblast Growth Factor 2 Sales (K Pcs) of Key Manufacturers (2016-2021) Table 6. Global Fibroblast Growth Factor 2 Sales Share by Manufacturers (2016-2021) Table 7. Global Fibroblast Growth Factor 2 Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Fibroblast Growth Factor 2 Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Fibroblast Growth Factor 2 Average Price (USD/Pcs) of Key Manufacturers (2016-2021) Table 10. Manufacturers Fibroblast Growth Factor 2 Manufacturing Sites and Area Served Table 11. Manufacturers Fibroblast Growth Factor 2 Product Type Table 12. Global Fibroblast Growth Factor 2 Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Fibroblast Growth Factor 2 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fibroblast Growth Factor 2 as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Fibroblast Growth Factor 2 Sales by Region (2016-2021) & (K Pcs) Table 16. Global Fibroblast Growth Factor 2 Sales Market Share by Region (2016-2021) Table 17. Global Fibroblast Growth Factor 2 Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Fibroblast Growth Factor 2 Sales by Country (2016-2021) & (K Pcs) Table 19. North America Fibroblast Growth Factor 2 Sales Market Share by Country (2016-2021) Table 20. North America Fibroblast Growth Factor 2 Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Fibroblast Growth Factor 2 Revenue Market Share by Country (2016-2021) Table 22. Europe Fibroblast Growth Factor 2 Sales by Country (2016-2021) & (K Pcs) Table 23. Europe Fibroblast Growth Factor 2 Sales Market Share by Country (2016-2021) Table 24. Europe Fibroblast Growth Factor 2 Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Fibroblast Growth Factor 2 Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Fibroblast Growth Factor 2 Sales by Region (2016-2021) & (K Pcs) Table 27. Asia Pacific Fibroblast Growth Factor 2 Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Fibroblast Growth Factor 2 Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Fibroblast Growth Factor 2 Revenue Market Share by Region (2016-2021) Table 30. Latin America Fibroblast Growth Factor 2 Sales by Country (2016-2021) & (K Pcs) Table 31. Latin America Fibroblast Growth Factor 2 Sales Market Share by Country (2016-2021) Table 32. Latin America Fibroblast Growth Factor 2 Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Fibroblast Growth Factor 2 Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Fibroblast Growth Factor 2 Sales by Country (2016-2021) & (K Pcs) Table 35. Middle East and Africa Fibroblast Growth Factor 2 Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Fibroblast Growth Factor 2 Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Fibroblast Growth Factor 2 Revenue Market Share by Country (2016-2021) Table 38. Global Fibroblast Growth Factor 2 Sales (K Pcs) by Type (2016-2021) Table 39. Global Fibroblast Growth Factor 2 Sales Market Share by Type (2016-2021) Table 40. Global Fibroblast Growth Factor 2 Revenue (Million US$) by Type (2016-2021) Table 41. Global Fibroblast Growth Factor 2 Revenue Share by Type (2016-2021) Table 42. Global Fibroblast Growth Factor 2 Price (USD/Pcs) by Type (2016-2021) Table 43. Global Fibroblast Growth Factor 2 Sales (K Pcs) by Application (2016-2021) Table 44. Global Fibroblast Growth Factor 2 Sales Market Share by Application (2016-2021) Table 45. Global Fibroblast Growth Factor 2 Revenue (Million US$) by Application (2016-2021) Table 46. Global Fibroblast Growth Factor 2 Revenue Share by Application (2016-2021) Table 47. Global Fibroblast Growth Factor 2 Price (USD/Pcs) by Application (2016-2021) Table 48. ID Pharma Co Ltd Corporation Information Table 49. ID Pharma Co Ltd Description and Business Overview Table 50. ID Pharma Co Ltd Fibroblast Growth Factor 2 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 51. ID Pharma Co Ltd Fibroblast Growth Factor 2 Product Table 52. ID Pharma Co Ltd Recent Developments/Updates Table 53. Kringle Pharma Inc Corporation Information Table 54. Kringle Pharma Inc Description and Business Overview Table 55. Kringle Pharma Inc Fibroblast Growth Factor 2 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 56. Kringle Pharma Inc Fibroblast Growth Factor 2 Product Table 57. Kringle Pharma Inc Recent Developments/Updates Table 58. Ohr Pharmaceutical Inc Corporation Information Table 59. Ohr Pharmaceutical Inc Description and Business Overview Table 60. Ohr Pharmaceutical Inc Fibroblast Growth Factor 2 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 61. Ohr Pharmaceutical Inc Fibroblast Growth Factor 2 Product Table 62. Ohr Pharmaceutical Inc Recent Developments/Updates Table 63. Ribomic Inc Corporation Information Table 64. Ribomic Inc Description and Business Overview Table 65. Ribomic Inc Fibroblast Growth Factor 2 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 66. Ribomic Inc Fibroblast Growth Factor 2 Product Table 67. Ribomic Inc Recent Developments/Updates Table 68. Production Base and Market Concentration Rate of Raw Material Table 69. Key Suppliers of Raw Materials Table 70. Fibroblast Growth Factor 2 Distributors List Table 71. Fibroblast Growth Factor 2 Customers List Table 72. Fibroblast Growth Factor 2 Market Trends Table 73. Fibroblast Growth Factor 2 Growth Drivers Table 74. Fibroblast Growth Factor 2 Market Restraints Table 75. Global Fibroblast Growth Factor 2 Sales Forecast by Type (2022-2027) & (K Pcs) Table 76. Global Fibroblast Growth Factor 2 Sales Market Share Forecast by Type (2022-2027) Table 77. Global Fibroblast Growth Factor 2 Revenue Forecast by Type (2022-2027) & (US$ Million) Table 78. Global Fibroblast Growth Factor 2 Revenue Market Share Forecast by Type (2022-2027) Table 79. Global Fibroblast Growth Factor 2 Sales Forecast by Application (2022-2027) & (K Pcs) Table 80. Global Fibroblast Growth Factor 2 Sales Market Share Forecast by Application (2022-2027) Table 81. Global Fibroblast Growth Factor 2 Revenue Forecast by Application (2022-2027) & (US$ Million) Table 82. Global Fibroblast Growth Factor 2 Revenue Market Share Forecast by Application (2022-2027) Table 83. Global Fibroblast Growth Factor 2 Sales Forecast by Region (2022-2027) & (K Pcs) Table 84. Global Fibroblast Growth Factor 2 Sales Market Share Forecast by Region (2022-2027) Table 85. Global Fibroblast Growth Factor 2 Revenue Forecast by Region (2022-2027) & (US$ Million) Table 86. Global Fibroblast Growth Factor 2 Revenue Market Share Forecast by Region (2022-2027) Table 87. Research Programs/Design for This Report Table 88. Key Data Information from Secondary Sources Table 89. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Fibroblast Growth Factor 2 Figure 2. Global Fibroblast Growth Factor 2 Market Share by Type in 2020 & 2027 Figure 3. CT-400P Product Picture Figure 4. DVC-10101 Product Picture Figure 5. NK-4 Product Picture Figure 6. RBM-007 Product Picture Figure 7. Others Product Picture Figure 8. Global Fibroblast Growth Factor 2 Market Share by Application in 2020 & 2027 Figure 9. Achondroplasia Figure 10. Bone Diorders Figure 11. Cancer Pain Figure 12. Pancreatic Cancer Figure 13. Others Figure 14. Global Fibroblast Growth Factor 2 Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 15. Global Fibroblast Growth Factor 2 Market Size 2016-2027 (US$ Million) Figure 16. Global Fibroblast Growth Factor 2 Sales 2016-2027 (K Pcs) Figure 17. Global Fibroblast Growth Factor 2 Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 18. Fibroblast Growth Factor 2 Sales Share by Manufacturers in 2020 Figure 19. Global Fibroblast Growth Factor 2 Revenue Share by Manufacturers in 2020 Figure 20. The Global 5 and 10 Largest Fibroblast Growth Factor 2 Players: Market Share by Revenue in 2020 Figure 21. Fibroblast Growth Factor 2 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 22. Global Fibroblast Growth Factor 2 Sales Market Share by Region (2016-2021) Figure 23. Global Fibroblast Growth Factor 2 Sales Market Share by Region in 2020 Figure 24. Global Fibroblast Growth Factor 2 Revenue Market Share by Region (2016-2021) Figure 25. Global Fibroblast Growth Factor 2 Revenue Market Share by Region in 2020 Figure 26. U.S. Fibroblast Growth Factor 2 Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Canada Fibroblast Growth Factor 2 Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Germany Fibroblast Growth Factor 2 Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. France Fibroblast Growth Factor 2 Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. U.K. Fibroblast Growth Factor 2 Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. Italy Fibroblast Growth Factor 2 Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Russia Fibroblast Growth Factor 2 Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. China Fibroblast Growth Factor 2 Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Japan Fibroblast Growth Factor 2 Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. South Korea Fibroblast Growth Factor 2 Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. India Fibroblast Growth Factor 2 Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Australia Fibroblast Growth Factor 2 Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Taiwan Fibroblast Growth Factor 2 Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Indonesia Fibroblast Growth Factor 2 Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Thailand Fibroblast Growth Factor 2 Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Malaysia Fibroblast Growth Factor 2 Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Philippines Fibroblast Growth Factor 2 Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Vietnam Fibroblast Growth Factor 2 Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Mexico Fibroblast Growth Factor 2 Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Brazil Fibroblast Growth Factor 2 Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Argentina Fibroblast Growth Factor 2 Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Turkey Fibroblast Growth Factor 2 Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. Saudi Arabia Fibroblast Growth Factor 2 Revenue Growth Rate (2016-2021) (US$ Million) Figure 49. U.A.E Fibroblast Growth Factor 2 Revenue Growth Rate (2016-2021) (US$ Million) Figure 50. Sales Market Share of Fibroblast Growth Factor 2 by Type (2016-2021) Figure 51. Sales Market Share of Fibroblast Growth Factor 2 by Application (2016-2021) Figure 52. Sales Market Share of Fibroblast Growth Factor 2 by Application in 2020 Figure 53. Revenue Share of Fibroblast Growth Factor 2 by Application (2016-2021) Figure 54. Revenue Share of Fibroblast Growth Factor 2 by Application in 2020 Figure 55. Manufacturing Cost Structure of Fibroblast Growth Factor 2 Figure 56. Manufacturing Process Analysis of Fibroblast Growth Factor 2 Figure 57. Fibroblast Growth Factor 2 Industrial Chain Analysis Figure 58. Channels of Distribution Figure 59. Distributors Profiles Figure 60. Bottom-up and Top-down Approaches for This Report Figure 61. Data Triangulation Figure 62. Key Executives Interviewed

ID Pharma Co Ltd Kringle Pharma Inc Ohr Pharmaceutical Inc Ribomic Inc